Page last updated: 2024-09-03

sr 48692 and Drug Withdrawal Symptoms

sr 48692 has been researched along with Drug Withdrawal Symptoms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canteras, NS; Costa, FG; Felicio, LF; Frussa-Filho, R; Valera, AG1
Bérod, A; Espinosa, JM; Felszeghy, K; Pélaprat, D; Rostène, W; Scarna, H1

Other Studies

2 other study(ies) available for sr 48692 and Drug Withdrawal Symptoms

ArticleYear
Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability.
    Neuropeptides, 2007, Volume: 41, Issue:2

    Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Exploratory Behavior; Immunohistochemistry; Limbic System; Male; Mice; Motor Activity; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Pyrazoles; Quinolines; Receptors, Neurotensin; Substance Withdrawal Syndrome

2007
Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:12

    Topics: Analysis of Variance; Animals; Behavior, Animal; Cocaine; Conditioning, Operant; Drug Administration Schedule; Male; Motor Activity; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Substance Withdrawal Syndrome; Time Factors

2007